Bartholomeusz A - Search Results

1

Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase.

Angus P, Vaughan R, Xiong S, Yang H, Delaney W, Gibbs C, Brosgart C, Colledge D, Edwards R, Ayres A, Bartholomeusz A, Locarnini S. Angus P, et al. Among authors: bartholomeusz a. Gastroenterology. 2003 Aug;125(2):292-7. doi: 10.1016/s0016-5085(03)00939-9. Gastroenterology. 2003. PMID: 12891527

2

Advances in hepatitis C: what is coming in the next 5 years?

Locarnini SA, Bartholomeusz A. Locarnini SA, et al. Among authors: bartholomeusz a. J Gastroenterol Hepatol. 2002 Apr;17(4):442-7. doi: 10.1046/j.1440-1746.2002.02768.x. J Gastroenterol Hepatol. 2002. PMID: 11982725 Review.

3

Lamivudine resistance in patients with chronic hepatitis B: role of clinical and virological factors.

Thompson AJ, Ayres A, Yuen L, Bartholomeusz A, Bowden DS, Iser DM, Chen RY, Demediuk B, Shaw G, Bell SJ, Watson KJ, Locarnini SA, Desmond PV. Thompson AJ, et al. Among authors: bartholomeusz a. J Gastroenterol Hepatol. 2007 Jul;22(7):1078-85. doi: 10.1111/j.1440-1746.2006.04630.x. J Gastroenterol Hepatol. 2007. PMID: 17608854

4

Antiviral drug resistance: clinical consequences and molecular aspects.

Bartholomeusz A, Locarnini SA. Bartholomeusz A, et al. Semin Liver Dis. 2006 May;26(2):162-70. doi: 10.1055/s-2006-939758. Semin Liver Dis. 2006. PMID: 16673294 Review.

5

Evolving therapies for the treatment of chronic hepatitis B virus infection.

Delaney W 4th, Bartholomeusz A, Locarnini SA. Delaney W 4th, et al. Among authors: bartholomeusz a. Expert Opin Investig Drugs. 2002 Feb;11(2):169-87. doi: 10.1517/13543784.11.2.169. Expert Opin Investig Drugs. 2002. PMID: 11829711 Review.

6

Lamivudine and Famciclovir resistant hepatitis B virus associated with fatal hepatic failure.

Ayres A, Bartholomeusz A, Lau G, Lam KC, Lee JY, Locarnini S. Ayres A, et al. Among authors: bartholomeusz a. J Clin Virol. 2003 May;27(1):111-6. doi: 10.1016/s1386-6532(02)00167-1. J Clin Virol. 2003. PMID: 12727536

7

Prevalence and characterization of lamivudine-resistant hepatitis B virus mutations in HIV-HBV co-infected individuals.

Cooley L, Ayres A, Bartholomeusz A, Lewin S, Crowe S, Mijch A, Locarnini S, Sasadeusz J. Cooley L, et al. Among authors: bartholomeusz a. AIDS. 2003 Jul 25;17(11):1649-57. doi: 10.1097/00002030-200307250-00009. AIDS. 2003. PMID: 12853747

8

HBV genotyping and analysis for unique mutations.

Ayres A, Locarnini S, Bartholomeusz A. Ayres A, et al. Among authors: bartholomeusz a. Methods Mol Med. 2004;95:125-49. doi: 10.1385/1-59259-669-X:125. Methods Mol Med. 2004. PMID: 14762302 No abstract available.

9

HBV drug resistance: mechanisms, detection and interpretation.

Shaw T, Bartholomeusz A, Locarnini S. Shaw T, et al. Among authors: bartholomeusz a. J Hepatol. 2006 Mar;44(3):593-606. doi: 10.1016/j.jhep.2006.01.001. Epub 2006 Jan 19. J Hepatol. 2006. PMID: 16455151 Review. No abstract available.

10

SeqHepB: a sequence analysis program and relational database system for chronic hepatitis B.

Yuen LK, Ayres A, Littlejohn M, Colledge D, Edgely A, Maskill WJ, Locarnini SA, Bartholomeusz A. Yuen LK, et al. Among authors: bartholomeusz a. Antiviral Res. 2007 Jul;75(1):64-74. doi: 10.1016/j.antiviral.2006.11.014. Epub 2006 Dec 22. Antiviral Res. 2007. PMID: 17215050

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters